Werbung
Werbung
AMPH
Amphastar Pharmaceuticals, Inc.
27.73
USDGesponsert
-0.01
-0.03%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
27.74
+0.01
+0.03%
AMPH Ergebnisberichte
Positives Überraschungsverhältnis
AMPH übertreffen die 32 der letzten 40Schätzungen.
80%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$194.29M
/$0.94
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+1.28%
/+1.08%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+4.16%
/+2.17%
Amphastar Pharmaceuticals, Inc. earnings per share and revenue
On 06. Nov. 2025, AMPH reported earnings of 0.93 USD per share (EPS) for Q3 25, beating the estimate of 0.84 USD, resulting in a 10.58% surprise. Revenue reached 191.84 million, compared to an expected 188.42 million, with a 1.81% difference. The market reacted with a -0.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.94 USD, with revenue projected to reach 194.29 million USD, implying an increase of 1.08% EPS, and increase of 1.28% in Revenue from the last quarter.
FAQ
What were Amphastar Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Amphastar Pharmaceuticals, Inc. reported EPS of $0.93, beating estimates by 10.58%, and revenue of $191.84M, 1.81% above expectations.
How did the market react to Amphastar Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved down -0.83%, changed from $24.23 before the earnings release to $24.03 the day after.
When is Amphastar Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Amphastar Pharmaceuticals, Inc.'s next earnings report?
Based on 9
analysts, Amphastar Pharmaceuticals, Inc. is expected to report EPS of $0.94 and revenue of $194.29M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung